Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 189

1.

Assessment of boscalid and pyraclostrobin disappearance and behavior following application of effective microorganisms on apples.

Podbielska M, Szpyrka E, Piechowicz B, Sadło S, Sudoł M.

J Environ Sci Health B. 2018 Jul 19:1-9. doi: 10.1080/03601234.2018.1474554. [Epub ahead of print]

PMID:
30024824
2.

Host Protein BAG3 is a Negative Regulator of Lassa VLP Egress.

Han Z, Schwoerer MP, Hicks P, Liang J, Ruthel G, Berry CT, Freedman BD, Sagum CA, Bedford MT, Sidhu SS, Sudol M, Harty RN.

Diseases. 2018 Jul 13;6(3). pii: E64. doi: 10.3390/diseases6030064.

3.

Agave negatively regulates YAP and TAZ transcriptionally and post-translationally in osteosarcoma cell lines.

Ferraiuolo M, Pulito C, Finch-Edmondson M, Korita E, Maidecchi A, Donzelli S, Muti P, Serra M, Sudol M, Strano S, Blandino G.

Cancer Lett. 2018 Oct 1;433:18-32. doi: 10.1016/j.canlet.2018.06.021. Epub 2018 Jun 19.

4.

Biophysical studies and NMR structure of YAP2 WW domain - LATS1 PPxY motif complexes reveal the basis of their interaction.

Verma A, Jing-Song F, Finch-Edmondson ML, Velazquez-Campoy A, Balasegaran S, Sudol M, Sivaraman J.

Oncotarget. 2018 Jan 3;9(8):8068-8080. doi: 10.18632/oncotarget.23909. eCollection 2018 Jan 30.

5.

Developmental YAPdeltaC determines adult pathology in a model of spinocerebellar ataxia type 1.

Fujita K, Mao Y, Uchida S, Chen X, Shiwaku H, Tamura T, Ito H, Watase K, Homma H, Tagawa K, Sudol M, Okazawa H.

Nat Commun. 2017 Nov 30;8(1):1864. doi: 10.1038/s41467-017-01790-z.

6.

WW and C2 domain-containing proteins regulate hepatic cell differentiation and tumorigenesis through the hippo signaling pathway.

Hermann A, Wennmann DO, Gromnitza S, Edeling M, Van Marck V, Sudol M, Schaefer L, Duning K, Weide T, Pavenstädt H, Kremerskothen J.

Hepatology. 2018 Apr;67(4):1546-1559. doi: 10.1002/hep.29647. Epub 2018 Feb 18.

PMID:
29116649
7.

Ubiquitin Ligase WWP1 Interacts with Ebola Virus VP40 To Regulate Egress.

Han Z, Sagum CA, Takizawa F, Ruthel G, Berry CT, Kong J, Sunyer JO, Freedman BD, Bedford MT, Sidhu SS, Sudol M, Harty RN.

J Virol. 2017 Sep 27;91(20). pii: e00812-17. doi: 10.1128/JVI.00812-17. Print 2017 Oct 15.

8.

Correction: Chaperone-Mediated Autophagy Protein BAG3 Negatively Regulates Ebola and Marburg VP40-Mediated Egress.

Liang J, Sagum CA, Bedford MT, Sidhu SS, Sudol M, Han Z, Harty RN.

PLoS Pathog. 2017 Jul 19;13(7):e1006519. doi: 10.1371/journal.ppat.1006519. eCollection 2017 Jul.

9.

YAP Regulates Actin Dynamics through ARHGAP29 and Promotes Metastasis.

Qiao Y, Chen J, Lim YB, Finch-Edmondson ML, Seshachalam VP, Qin L, Jiang T, Low BC, Singh H, Lim CT, Sudol M.

Cell Rep. 2017 May 23;19(8):1495-1502. doi: 10.1016/j.celrep.2017.04.075.

10.

Framework to function: mechanosensitive regulators of gene transcription.

Finch-Edmondson M, Sudol M.

Cell Mol Biol Lett. 2016 Dec 7;21:28. doi: 10.1186/s11658-016-0028-7. eCollection 2016. Review.

11.

Roles of RUNX in Hippo Pathway Signaling.

Passaniti A, Brusgard JL, Qiao Y, Sudol M, Finch-Edmondson M.

Adv Exp Med Biol. 2017;962:435-448. doi: 10.1007/978-981-10-3233-2_26. Review.

PMID:
28299672
12.

Targeting TEAD/YAP-transcription-dependent necrosis, TRIAD, ameliorates Huntington's disease pathology.

Mao Y, Chen X, Xu M, Fujita K, Motoki K, Sasabe T, Homma H, Murata M, Tagawa K, Tamura T, Kaye J, Finkbeiner S, Blandino G, Sudol M, Okazawa H.

Hum Mol Genet. 2016 Nov 1;25(21):4749-4770. doi: 10.1093/hmg/ddw303.

PMID:
28171658
13.

Chaperone-Mediated Autophagy Protein BAG3 Negatively Regulates Ebola and Marburg VP40-Mediated Egress.

Liang J, Sagum CA, Bedford MT, Sidhu SS, Sudol M, Han Z, Harty RN.

PLoS Pathog. 2017 Jan 11;13(1):e1006132. doi: 10.1371/journal.ppat.1006132. eCollection 2017 Jan. Erratum in: PLoS Pathog. 2017 Jul 19;13(7):e1006519.

14.

PRMT5 C-terminal Phosphorylation Modulates a 14-3-3/PDZ Interaction Switch.

Espejo AB, Gao G, Black K, Gayatri S, Veland N, Kim J, Chen T, Sudol M, Walker C, Bedford MT.

J Biol Chem. 2017 Feb 10;292(6):2255-2265. doi: 10.1074/jbc.M116.760330. Epub 2016 Dec 28.

15.

Wnt Signaling Promotes Breast Cancer by Blocking ITCH-Mediated Degradation of YAP/TAZ Transcriptional Coactivator WBP2.

Lim SK, Lu SY, Kang SA, Tan HJ, Li Z, Adrian Wee ZN, Guan JS, Reddy Chichili VP, Sivaraman J, Putti T, Thike AA, Tan PH, Sudol M, Virshup DM, Chan SW, Hong W, Lim YP.

Cancer Res. 2016 Nov 1;76(21):6278-6289. Epub 2016 Aug 30.

16.

ITCH E3 Ubiquitin Ligase Interacts with Ebola Virus VP40 To Regulate Budding.

Han Z, Sagum CA, Bedford MT, Sidhu SS, Sudol M, Harty RN.

J Virol. 2016 Sep 29;90(20):9163-71. doi: 10.1128/JVI.01078-16. Print 2016 Oct 15.

17.

Changes in the folding landscape of the WW domain provide a molecular mechanism for an inherited genetic syndrome.

Pucheta-Martinez E, D'Amelio N, Lelli M, Martinez-Torrecuadrada JL, Sudol M, Saladino G, Gervasio FL.

Sci Rep. 2016 Jul 26;6:30293. doi: 10.1038/srep30293.

18.

Phosphorylation of Tyr188 in the WW domain of YAP1 plays an essential role in YAP1-induced cellular transformation.

Li YW, Guo J, Shen H, Li J, Yang N, Frangou C, Wilson KE, Zhang Y, Mussell AL, Sudol M, Farooq A, Qu J, Zhang J.

Cell Cycle. 2016 Sep 16;15(18):2497-505. doi: 10.1080/15384101.2016.1207836. Epub 2016 Jul 18.

19.

Experimental Model for Successful Liver Cell Therapy by Lenti TTR-YapERT2 Transduced Hepatocytes with Tamoxifen Control of Yap Subcellular Location.

Yovchev M, Jaber FL, Lu Z, Patel S, Locker J, Rogler LE, Murray JW, Sudol M, Dabeva MD, Zhu L, Shafritz DA.

Sci Rep. 2016 Jan 14;6:19275. doi: 10.1038/srep19275.

20.

TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells.

Finch-Edmondson ML, Strauss RP, Passman AM, Sudol M, Yeoh GC, Callus BA.

J Biol Chem. 2015 Nov 13;290(46):27928-38. doi: 10.1074/jbc.M115.692285. Epub 2015 Oct 2.

21.

RUNX3 is a novel negative regulator of oncogenic TEAD-YAP complex in gastric cancer.

Qiao Y, Lin SJ, Chen Y, Voon DC, Zhu F, Chuang LS, Wang T, Tan P, Lee SC, Yeoh KG, Sudol M, Ito Y.

Oncogene. 2016 May 19;35(20):2664-74. doi: 10.1038/onc.2015.338. Epub 2015 Sep 14.

PMID:
26364597
22.

RUNX2 and TAZ-dependent signaling pathways regulate soluble E-Cadherin levels and tumorsphere formation in breast cancer cells.

Brusgard JL, Choe M, Chumsri S, Renoud K, MacKerell AD Jr, Sudol M, Passaniti A.

Oncotarget. 2015 Sep 29;6(29):28132-50. doi: 10.18632/oncotarget.4654.

23.

Systematic review of adjunct therapies to improve outcomes following botulinum toxin injection for treatment of limb spasticity.

Mills PB, Finlayson H, Sudol M, O'Connor R.

Clin Rehabil. 2016 Jun;30(6):537-48. doi: 10.1177/0269215515593783. Epub 2015 Jul 21. Review.

PMID:
26198891
24.

Allostery mediates ligand binding to WWOX tumor suppressor via a conformational switch.

Schuchardt BJ, Mikles DC, Bhat V, McDonald CB, Sudol M, Farooq A.

J Mol Recognit. 2015 Apr;28(4):220-31. doi: 10.1002/jmr.2419. Epub 2015 Feb 19.

25.

WW domains of the yes-kinase-associated-protein (YAP) transcriptional regulator behave as independent units with different binding preferences for PPxY motif-containing ligands.

Iglesias-Bexiga M, Castillo F, Cobos ES, Oka T, Sudol M, Luque I.

PLoS One. 2015 Jan 21;10(1):e0113828. doi: 10.1371/journal.pone.0113828. eCollection 2015.

26.

Neuregulin 1-activated ERBB4 as a "dedicated" receptor for the Hippo-YAP pathway.

Sudol M.

Sci Signal. 2014 Dec 9;7(355):pe29. doi: 10.1126/scisignal.aaa2710. Review.

PMID:
25492964
27.

Ligand binding to WW tandem domains of YAP2 transcriptional regulator is under negative cooperativity.

Schuchardt BJ, Mikles DC, Hoang LM, Bhat V, McDonald CB, Sudol M, Farooq A.

FEBS J. 2014 Dec;281(24):5532-51. doi: 10.1111/febs.13095. Epub 2014 Nov 4.

28.

(R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells.

Barsyte-Lovejoy D, Li F, Oudhoff MJ, Tatlock JH, Dong A, Zeng H, Wu H, Freeman SA, Schapira M, Senisterra GA, Kuznetsova E, Marcellus R, Allali-Hassani A, Kennedy S, Lambert JP, Couzens AL, Aman A, Gingras AC, Al-Awar R, Fish PV, Gerstenberger BS, Roberts L, Benn CL, Grimley RL, Braam MJ, Rossi FM, Sudol M, Brown PJ, Bunnage ME, Owen DR, Zaph C, Vedadi M, Arrowsmith CH.

Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12853-8. doi: 10.1073/pnas.1407358111. Epub 2014 Aug 18.

29.

Geranylgeranylation signals to the Hippo pathway for breast cancer cell proliferation and migration.

Mi W, Lin Q, Childress C, Sudol M, Robishaw J, Berlot CH, Shabahang M, Yang W.

Oncogene. 2015 Jun 11;34(24):3095-106. doi: 10.1038/onc.2014.251. Epub 2014 Aug 11.

PMID:
25109332
30.

The Hippo signal transduction network in skeletal and cardiac muscle.

Wackerhage H, Del Re DP, Judson RN, Sudol M, Sadoshima J.

Sci Signal. 2014 Aug 5;7(337):re4. doi: 10.1126/scisignal.2005096. Review.

PMID:
25097035
31.

In utero gene therapy rescues microcephaly caused by Pqbp1-hypofunction in neural stem progenitor cells.

Ito H, Shiwaku H, Yoshida C, Homma H, Luo H, Chen X, Fujita K, Musante L, Fischer U, Frints SG, Romano C, Ikeuchi Y, Shimamura T, Imoto S, Miyano S, Muramatsu SI, Kawauchi T, Hoshino M, Sudol M, Arumughan A, Wanker EE, Rich T, Schwartz C, Matsuzaki F, Bonni A, Kalscheuer VM, Okazawa H.

Mol Psychiatry. 2015 Apr;20(4):459-71. doi: 10.1038/mp.2014.69. Epub 2014 Jul 29.

32.

ZO proteins redundantly regulate the transcription factor DbpA/ZONAB.

Spadaro D, Tapia R, Jond L, Sudol M, Fanning AS, Citi S.

J Biol Chem. 2014 Aug 8;289(32):22500-11. doi: 10.1074/jbc.M114.556449. Epub 2014 Jul 1.

33.

Yes-associated protein (YAP) modulates oncogenic features and radiation sensitivity in endometrial cancer.

Tsujiura M, Mazack V, Sudol M, Kaspar HG, Nash J, Carey DJ, Gogoi R.

PLoS One. 2014 Jun 27;9(6):e100974. doi: 10.1371/journal.pone.0100974. eCollection 2014.

34.

YAP/TAZ as mechanosensors and mechanotransducers in regulating organ size and tumor growth.

Low BC, Pan CQ, Shivashankar GV, Bershadsky A, Sudol M, Sheetz M.

FEBS Lett. 2014 Aug 19;588(16):2663-70. doi: 10.1016/j.febslet.2014.04.012. Epub 2014 Apr 18. Review.

35.

Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.

Abu-Odeh M, Bar-Mag T, Huang H, Kim T, Salah Z, Abdeen SK, Sudol M, Reichmann D, Sidhu S, Kim PM, Aqeilan RI.

J Biol Chem. 2014 Mar 28;289(13):8865-80. doi: 10.1074/jbc.M113.506790. Epub 2014 Feb 18.

36.

Molecular basis of the binding of YAP transcriptional regulator to the ErbB4 receptor tyrosine kinase.

Schuchardt BJ, Bhat V, Mikles DC, McDonald CB, Sudol M, Farooq A.

Biochimie. 2014 Jun;101:192-202. doi: 10.1016/j.biochi.2014.01.011. Epub 2014 Jan 25.

37.

Death of a Titan.

Sudol M, Yaffe MB.

Sci Signal. 2013 Dec 17;6(306):eg6. doi: 10.1126/scisignal.2004914.

PMID:
24345678
38.

Molecular origin of the binding of WWOX tumor suppressor to ErbB4 receptor tyrosine kinase.

Schuchardt BJ, Bhat V, Mikles DC, McDonald CB, Sudol M, Farooq A.

Biochemistry. 2013 Dec 23;52(51):9223-36. doi: 10.1021/bi400987k. Epub 2013 Dec 13.

39.

The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis.

Yi C, Shen Z, Stemmer-Rachamimov A, Dawany N, Troutman S, Showe LC, Liu Q, Shimono A, Sudol M, Holmgren L, Stanger BZ, Kissil JL.

Sci Signal. 2013 Sep 3;6(291):ra77. doi: 10.1126/scisignal.2004060.

40.

ATM kinase enables the functional axis of YAP, PML and p53 to ameliorate loss of Werner protein-mediated oncogenic senescence.

Fausti F, Di Agostino S, Cioce M, Bielli P, Sette C, Pandolfi PP, Oren M, Sudol M, Strano S, Blandino G.

Cell Death Differ. 2013 Nov;20(11):1498-509. doi: 10.1038/cdd.2013.101. Epub 2013 Aug 9.

41.

Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanoma.

Nallet-Staub F, Marsaud V, Li L, Gilbert C, Dodier S, Bataille V, Sudol M, Herlyn M, Mauviel A.

J Invest Dermatol. 2014 Jan;134(1):123-132. doi: 10.1038/jid.2013.319. Epub 2013 Jul 29.

42.

Yes-associated protein (YAP) promotes cell survival by inhibiting proapoptotic dendrin signaling.

Campbell KN, Wong JS, Gupta R, Asanuma K, Sudol M, He JC, Mundel P.

J Biol Chem. 2013 Jun 14;288(24):17057-62. doi: 10.1074/jbc.C113.457390. Epub 2013 May 10.

43.

An evolutionary shift in the regulation of the Hippo pathway between mice and flies.

Bossuyt W, Chen CL, Chen Q, Sudol M, McNeill H, Pan D, Kopp A, Halder G.

Oncogene. 2014 Mar 6;33(10):1218-28. doi: 10.1038/onc.2013.82. Epub 2013 Apr 8.

44.

PML Surfs into HIPPO Tumor Suppressor Pathway.

Strano S, Fausti F, Di Agostino S, Sudol M, Blandino G.

Front Oncol. 2013 Mar 1;3:36. doi: 10.3389/fonc.2013.00036. eCollection 2013.

45.

YAP1 oncogene and its eight isoforms.

Sudol M.

Oncogene. 2013 Aug 15;32(33):3922. doi: 10.1038/onc.2012.520. Epub 2012 Nov 19. No abstract available.

PMID:
23160371
46.

WW domains in the heart of Smad regulation.

Sudol M.

Structure. 2012 Oct 10;20(10):1619-20. doi: 10.1016/j.str.2012.09.007.

47.

Identification, basic characterization and evolutionary analysis of differentially spliced mRNA isoforms of human YAP1 gene.

Gaffney CJ, Oka T, Mazack V, Hilman D, Gat U, Muramatsu T, Inazawa J, Golden A, Carey DJ, Farooq A, Tromp G, Sudol M.

Gene. 2012 Nov 10;509(2):215-22. doi: 10.1016/j.gene.2012.08.025. Epub 2012 Aug 24.

48.

Alternative nucleophilic substrates for the endonuclease activities of human immunodeficiency virus type 1 integrase.

Ealy JB, Sudol M, Krzeminski J, Amin S, Katzman M.

Virology. 2012 Nov 10;433(1):149-56. doi: 10.1016/j.virol.2012.07.022. Epub 2012 Aug 19.

49.

Modularity and functional plasticity of scaffold proteins as p(l)acemakers in cell signaling.

Pan CQ, Sudol M, Sheetz M, Low BC.

Cell Signal. 2012 Nov;24(11):2143-65. doi: 10.1016/j.cellsig.2012.06.002. Epub 2012 Jun 25. Review.

50.

Special issue - modular protein domains.

Sudol M, Cesareni G, Superti-Furga G, Just W.

FEBS Lett. 2012 Aug 14;586(17):2571. doi: 10.1016/j.febslet.2012.06.005. Epub 2012 Jun 17. No abstract available.

Supplemental Content

Support Center